Department of Nephrology, Zhongshan Hospital Affiliated to Xiamen University, No. 201-209 Hubinnan Road, Siming District, Xiamen 361000, China.
School of Bioengineering, Dalian University of Technology, No. 2 Linggong Road, Dalian 116024, China.
Bioconjug Chem. 2021 May 19;32(5):909-915. doi: 10.1021/acs.bioconjchem.1c00164. Epub 2021 Apr 23.
Polymeric small interfering RNA (siRNA) conjugate was elaborated to sequentially circumvent the predefined biological barriers encountered in the journey of transcellular delivery of siRNA into cytosol. Herein, classic ring-opening polymerization was employed for synthesis of well-defined poly(amino acid) derivatives possessing an array of carboxyl groups in an attempt to resemble the structural characteristics of hyaluronan. Furthermore, the hyaluronan-like synthetic was conjugated with a multiple of siRNA through a glutathione (GSH)-responsive disulfide linkage. The siRNA conjugate appeared to utilize the hyaluronan-specific receptors of CD44 for cell internalization, indicating similar functionalities to our hyaluronan-mimicking synthetic. Furthermore, the carboxyl groups of hyaluronan-like synthetics were designed to be selectively detached in subcellular acidic endosomes/lysosomes and transform into the cytomembrane-disruptive flanking ethylenediamine moieties, which appeared to be crucial in facilitating translocation of siRNA payloads from entrapment and degradation in lysosomes toward the cytosol. Eventually, active siRNA could be smoothly released from the synthetic due to the GSH cleavage disulfide linkage (disulfide), consequently accounting for potent RNA knockdown activities (>90%) toward cancerous cells. In addition, appreciable knockdown of parathyroid hormone was also achieved from our proposed siRNA conjugates in parathyroid cells. Hence, the elaborated siRNA conjugate showed tremendous potential in treatment of hyperparathyroidism, and could be developed further for systemic RNA interference (RNAi) therapeutics. Moreover, this study could also be the first example of a synthetic mimic to hyaluronan acquiring its functionalities, which could have important implications for further development of biomimic materials in pursuit of biomedical applications.
聚合物小干扰 RNA(siRNA)缀合物被精心设计,以顺序绕过 siRNA 转胞递送进入细胞质过程中遇到的预定生物屏障。在此,经典的开环聚合被用于合成具有一系列羧基的明确的聚(氨基酸)衍生物,试图模仿透明质酸的结构特征。此外,透明质酸样合成物通过谷胱甘肽(GSH)响应的二硫键连接与多个 siRNA 缀合。siRNA 缀合物似乎利用 CD44 的透明质酸特异性受体进行细胞内化,表明与我们的透明质酸模拟合成物具有相似的功能。此外,透明质酸样合成物的羧基被设计为在亚细胞酸性内体/溶酶体中选择性地脱离,并转化为破坏细胞质膜的侧翼乙二胺部分,这似乎对于促进 siRNA 有效负载从溶酶体的捕获和降解向细胞质的易位至关重要。最终,由于 GSH 切割二硫键(二硫键),活性 siRNA 可以从合成物中顺利释放,从而导致对癌细胞的有效 RNA 敲低活性(>90%)。此外,我们提出的 siRNA 缀合物在甲状旁腺细胞中也能显著降低甲状旁腺激素的表达。因此,精心设计的 siRNA 缀合物在治疗甲状旁腺功能亢进症方面具有巨大的潜力,并可进一步开发用于全身 RNA 干扰(RNAi)治疗。此外,这项研究也可能是第一个模仿透明质酸获得其功能的合成物的例子,这对于进一步开发仿生材料以追求生物医学应用具有重要意义。